{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:21:04Z","timestamp":1762017664211},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T00:00:00Z","timestamp":1367798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Res"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2047-1440-2-7","type":"journal-article","created":{"date-parts":[[2013,5,5]],"date-time":"2013-05-05T20:14:25Z","timestamp":1367784865000},"source":"Crossref","is-referenced-by-count":22,"title":["Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol"],"prefix":"10.1186","volume":"2","author":[{"given":"Richard","family":"Haynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Landray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argiris","family":"Asderakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Macdougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidambaram","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chas","family":"Newstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Pararajasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Puliatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Rigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sheerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Friend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,6]]},"reference":[{"issue":"23","key":"30_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant 10.1056\/NEJM199912023412303. N Eng J Med. 1999, 341 (23): 1725-1730. 10.1056\/NEJM199912023412303.","journal-title":"N Eng J Med"},{"issue":"8","key":"30_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1600-6143.2004.00515.x","volume":"4","author":"HU Meier-Kriesche","year":"2004","unstructured":"Meier-Kriesche HU, Schold JD, Kaplan B: Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant. 2004, 4 (8): 1289-1295. 10.1111\/j.1600-6143.2004.00515.x.","journal-title":"Am J Transplant"},{"issue":"10","key":"30_CR3","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1681\/ASN.2005050463","volume":"16","author":"JR Chapman","year":"2005","unstructured":"Chapman JR, O\u2019Connell PJ, Nankivell BJ: Chronic renal allograft dysfunction. J Am Soc Nephrology: JASN. 2005, 16 (10): 3015-3026. 10.1681\/ASN.2005050463.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"24","key":"30_CR4","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell BJ, Borrows RJ, Fung CL, O\u2019Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Eng J Med. 2003, 349 (24): 2326-2333. 10.1056\/NEJMoa020009.","journal-title":"N Eng J Med"},{"issue":"25","key":"30_CR5","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, Margreiter R, Hugo C, Grinyo JM, Frei U: Reduced exposure to calcineurin inhibitors in renal transplantation. N Eng J Med. 2007, 357 (25): 2562-2575. 10.1056\/NEJMoa067411.","journal-title":"N Eng J Med"},{"issue":"1","key":"30_CR6","first-page":"869","volume":"27","author":"PJ Friend","year":"1995","unstructured":"Friend PJ, Rebello P, Oliveira D, Manna V, Cobbold SP, Hale G, Jamieson NV, Jamieson I, Calne RY, Harris DT: Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Transplant Proc. 1995, 27 (1): 869-870.","journal-title":"Transplant Proc"},{"issue":"1 Suppl 2","key":"30_CR7","first-page":"375","volume":"82","author":"E Huang","year":"2006","unstructured":"Huang E, Cho Y, Shah T, Peng A, Hayashi R, Bunnapradist S: Alemtuzumab induction in living donor kidney transplantation a multivariate analysis of the optn\/ unos database. Transplantation. 2006, 82 (1 Suppl 2): 375-376.","journal-title":"Transplantation"},{"issue":"12","key":"30_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/TP.0b013e318257ad41","volume":"93","author":"RD Morgan","year":"2012","unstructured":"Morgan RD, O\u2019Callaghan JM, Knight SR, Morris PJ: Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Transplantation. 2012, 93 (12): 1179-1188. 10.1097\/TP.0b013e318257ad41.","journal-title":"Transplantation"},{"issue":"20","key":"30_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","volume":"364","author":"MJ Hanaway","year":"2011","unstructured":"Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J: Alemtuzumab induction in renal transplantation. N Eng J Med. 2011, 364 (20): 1909-1919. 10.1056\/NEJMoa1009546.","journal-title":"N Eng J Med"},{"issue":"10 Suppl","key":"30_CR10","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.transproceed.2008.10.013","volume":"40","author":"SM Flechner","year":"2008","unstructured":"Flechner SM: Reviewing the evidence for de novo immunosuppression with sirolimus. Transplant Proc. 2008, 40 (10 Suppl): S25-S28.","journal-title":"Transplant Proc"},{"issue":"2","key":"30_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","volume":"87","author":"FP Schena","year":"2009","unstructured":"Schena FP, Pascoe MD, Alberu J, del Carmen RM, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R: Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation. 2009, 87 (2): 233-242. 10.1097\/TP.0b013e3181927a41.","journal-title":"Transplantation"},{"issue":"5","key":"30_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","volume":"9","author":"Y Lebranchu","year":"2009","unstructured":"Lebranchu Y, Thierry A, Toupance O, Westeel PF, Etienne I, Thervet E, Moulin B, Frouget T, Le Meur Y, Glotz D: Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant. 2009, 9 (5): 1115-1123. 10.1111\/j.1600-6143.2009.02615.x.","journal-title":"Am J Transplant"},{"issue":"9768","key":"30_CR13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","volume":"377","author":"K Budde","year":"2011","unstructured":"Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F: Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet. 2011, 377 (9768): 837-847. 10.1016\/S0140-6736(10)62318-5.","journal-title":"Lancet"},{"issue":"8","key":"30_CR14","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","volume":"11","author":"Y Lebranchu","year":"2011","unstructured":"Lebranchu Y, Thierry A, Thervet E, Buchler M, Etienne I, Westeel PF, de Ligny HB, Moulin B, Rerolle JP, Frouget T: Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study. Am J Transplant. 2011, 11 (8): 1665-1675. 10.1111\/j.1600-6143.2011.03637.x.","journal-title":"Am J Transplant"},{"issue":"10","key":"30_CR15","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1097\/00007890-199811270-00021","volume":"66","author":"Y Li","year":"1998","unstructured":"Li Y, Zheng XX, Li XC, Zand MS, Strom TB: Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation. 1998, 66 (10): 1387-1388. 10.1097\/00007890-199811270-00021.","journal-title":"Transplantation"},{"key":"30_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol. 1994, 12: 991-1045. 10.1146\/annurev.iy.12.040194.005015.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"30_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.tp.0000174341.49741.8f","volume":"80","author":"AD Kirk","year":"2005","unstructured":"Kirk AD, Mannon RB, Kleiner DE, Swanson JS, Kampen RL, Cendales LK, Elster EA, Wakefield T, Chamberlain C, Hoffmann SC: Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation. 2005, 80 (8): 1051-1059. 10.1097\/01.tp.0000174341.49741.8f.","journal-title":"Transplantation"},{"issue":"10","key":"30_CR18","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1111\/j.1600-6143.2006.01495.x","volume":"6","author":"HP Tan","year":"2006","unstructured":"Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, Wu C, Donaldson J, Dvorchik I, Kayler L, Marcos A: Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant. 2006, 6 (10): 2409-2417. 10.1111\/j.1600-6143.2006.01495.x.","journal-title":"Am J Transplant"},{"issue":"11","key":"30_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1432-2277.2006.00388.x","volume":"19","author":"RN Barth","year":"2006","unstructured":"Barth RN, Janus CA, Lillesand CA, Radke NA, Pirsch JD, Becker BN, Fernandez LA, Thomas Chin L, Becker YT, Odorico JS: Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int. 2006, 19 (11): 885-892. 10.1111\/j.1432-2277.2006.00388.x.","journal-title":"Transpl Int"},{"issue":"3","key":"30_CR20","first-page":"301","volume":"101","author":"R Calne","year":"2000","unstructured":"Calne R, Moffatt SD, Friend PJ, Jamieson NV, Bradley JA, Hale G, Firth J, Bradley J, Smith KG, Waldmann H: Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Nippon Geka Gakkai Zasshi. 2000, 101 (3): 301-306.","journal-title":"Nippon Geka Gakkai Zasshi"},{"issue":"2","key":"30_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.4049\/jimmunol.177.2.944","volume":"177","author":"D Valmori","year":"2006","unstructured":"Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L, Wang Y, Ayyoub M: Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol. 2006, 177 (2): 944-949.","journal-title":"J Immunol"},{"key":"30_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/15260","volume":"5","author":"AD Wells","year":"1999","unstructured":"Wells AD, Li XC: Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med. 1999, 5: 1303-10.1038\/15260.","journal-title":"Nat Med"},{"issue":"1","key":"30_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.tp.0000191940.13473.59","volume":"81","author":"DD Bloom","year":"2006","unstructured":"Bloom DD, Hu H, Fechner JH, Knechtle SJ: T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation. 2006, 81 (1): 81-87. 10.1097\/01.tp.0000191940.13473.59.","journal-title":"Transplantation"},{"issue":"3","key":"30_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2215\/CJN.01741105","volume":"1","author":"L Gallon","year":"2006","unstructured":"Gallon L, Gagliardini E, Benigni A, Kaufman D, Waheed A, Noris M, Remuzzi G: Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H). Clin J Am Soc Nephrol. 2006, 1 (3): 539-545. 10.2215\/CJN.01741105.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"30_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130 (6): 461-470. 10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"issue":"9","key":"30_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/01.tp.0000237101.58974.43","volume":"82","author":"AV Mulay","year":"2006","unstructured":"Mulay AV, Cockfield S, Stryker R, Fergusson D, Knoll GA: Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation. 2006, 82 (9): 1153-1162. 10.1097\/01.tp.0000237101.58974.43.","journal-title":"Transplantation"},{"issue":"5","key":"30_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","volume":"27","author":"S Yusuf","year":"1985","unstructured":"Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985, 27 (5): 335-371. 10.1016\/S0033-0620(85)80003-7.","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"30_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","volume":"11","author":"AJ Matas","year":"2011","unstructured":"Matas AJ: Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am J Transplant. 2011, 11 (4): 687-692. 10.1111\/j.1600-6143.2011.03505.x.","journal-title":"Am J Transplant"},{"issue":"4","key":"30_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","volume":"11","author":"JR Chapman","year":"2011","unstructured":"Chapman JR: Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am J Transplant. 2011, 11 (4): 693-697. 10.1111\/j.1600-6143.2011.03504.x.","journal-title":"Am J Transplant"},{"issue":"3","key":"30_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1681\/ASN.2006101143","volume":"18","author":"M Noris","year":"2007","unstructured":"Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F: Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrology: JASN. 2007, 18 (3): 1007-1018. 10.1681\/ASN.2006101143.","journal-title":"J Am Soc Nephrology: JASN"}],"container-title":["Transplantation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-1440-2-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2047-1440-2-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-1440-2-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:45:41Z","timestamp":1548139541000},"score":1,"resource":{"primary":{"URL":"https:\/\/transplantationresearch.biomedcentral.com\/articles\/10.1186\/2047-1440-2-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1186\/2047-1440-2-7","relation":{},"ISSN":["2047-1440"],"issn-type":[{"value":"2047-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,6]]},"article-number":"7"}}